Displaying drugs 8101 - 8125 of 10589 in total
5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal
Experimental
Matched Iupac: … 5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanal …
Guanosine 5'-diphosphate 2':3'-cyclic monophosphate
Experimental
Matched Iupac: … oxo-6,9-dihydro-3H-purin-9-yl)-2-hydroxy-2-oxo-tetrahydro-2H-2lambda5-furo[3,4-d][1,3,2]dioxaphosphol-4- …
Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline
Experimental
{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)
Experimental
Matched Iupac: … ({4-[2-(1H-1,2,3-benzotriazol-1-yl)-3-{4-[difluoro(phosphono)methyl]phenyl}-2-(3,4-difluorophenyl)propyl …
LJP-538
Investigational
Amineptine
The Food and Drug Administration suspended the marketing authorisation for Survector in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until 2005.
Illicit
Withdrawn
Trimazosin
Trimazosin is a sympatholytic alpha blocker.
Experimental
Matched Iupac: … 2-hydroxy-2-methylpropyl 4-(4-amino-6,7,8-trimethoxyquinazolin-2-yl)piperazine-1-carboxylate …
METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID
Experimental
TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE
Experimental
Dodecyl sulfate
Experimental
Glenzocimab
Investigational
Peresolimab
Peresolimab is under investigation in clinical trial NCT04634253 (A Study of LY3462817 in Participants With Rheumatoid Arthritis).
Investigational
Tricarbonyl(1,10-phenanthroline)rhenium(1+)
Experimental
Teprasiran
Teprasiran is under investigation in clinical trial NCT03510897 (QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery).
Investigational
Displaying drugs 8101 - 8125 of 10589 in total